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ABSTRACT 
The Feasibility of an Advanced Practice Registered Nurse-Managed ADHD Resource 
Center in Missouri  
 Attention Deficit/Hyperactivity Disorder is a common neurobehavioral condition 
affecting 8-10% of the school age population.  ADHD affects every aspect of a child’s 
life.  A nationwide shortage of mental health specialists has caused an influx of patients 
seeking treatment from primary care providers for mental health conditions such as 
ADHD.  A literature review documented research that shows primary care providers are 
not always comfortable diagnosing and managing ADHD as well as inconsistency in the 
use of clinical practice guidelines for the diagnosis and management of ADHD which 
increases the risk of over diagnosis, under diagnosis, and misdiagnosis. 
 The primary objective of this project was to develop a survey to determine 
provider receptiveness to referring patients to an APRN-managed center for the diagnosis 
and management of Attention Deficit/Hyperactivity Disorder.  A secondary aim of this 
project was to develop a business plan for the center, provided feedback from the surveys 
was determined to be supportive. 
 The majority of both physicians and APRNs answered they were aware that CPGs 
for the diagnosis and management of ADHD existed (physician group 82.6% vs. NP 
group 87.5%) and that they used them to evaluate and treat their patients (physician 
group 65.2% vs. NP group 50%).  However, a substantial portion answered they did not 
use CPGs (physician group 26% vs. NP group 37.5%).  In this study, 50% of the APRN 
group answered that they were uncomfortable with diagnosing ADHD, as compared with 
the physician group who were “Very Comfortable” to “Comfortable” (47.8% and 47.8%).  
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 Almost 70% of physician subjects expressed a willingness to refer to an ADHD 
specialty center in contrast to 100% of APRNs reporting they would refer to such a 
center.  However, when asked if they would refer to a specialty center for the diagnosis 
and management of ADHD by an APRN, less than half of those willing in the physician 
group would refer (33.3%) as compared to 87.5% of APRNs.  Since there was 
insufficient community support for this type of center, a business plan was not developed. 
  This project yielded several implications for further research. More work is 
needed to establish why clinical practice guidelines are not being used consistently to 
diagnose and manage ADHD.  More research is needed to determine the reasons APRNs 
are not as comfortable diagnosing and managing ADHD compared to the physician 
group.  Finally, further work is needed to explore and explain the finding that physicians 
in this sample expressed a willingness to refer to an ADHD specialty center for diagnosis 
and management of ADHD, but not to a center managed by an APRN.   
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The Feasibility of an Advance Practice Registered Nurse-Managed ADHD Center in 
Missouri  
PROJECT PURPOSE 
Attention Deficit Hyperactivity Disorder (ADHD) is one of the most common 
neurobehavioral conditions in childhood (Center for Disease Control, 2011).  This 
chronic condition is characterized by inattention, distractibility, impulsivity and 
restlessness.  These characteristics are pervasive, impairing how a child functions at 
home, in school, and in the community.  Left untreated, ADHD increases a child’s risk of 
school failure, altered self-esteem, criminality, substance abuse, and other psychiatric 
disorders, as well as causes discord in families (McDonnell & Moffett, 2010). 
 A nationwide shortage of mental health specialists has caused an influx of patients 
seeking treatment from primary care providers for mental health conditions such as 
ADHD (Thomas, Ellis, Konrad, Holzer, & Morrissey, 2009).  Unfortunately, many 
primary care providers are not comfortable diagnosing and treating mental health 
conditions (Fremont, Nastasi, Newman, & Roizen, 2008), or simply do not have the time 
and resources needed to deal with diagnosis and management of mental health conditions 
in the office setting (Vlam, 2006).   
 The purpose of this project was to determine the feasibility of developing and 
implementing an advanced practice registered nurse (APRN)-managed center 
specializing in the diagnosis and treatment of children and adolescents with ADHD in 
Jefferson County, Missouri.  A secondary aim of this project was to develop a business 
plan for the center, provided feedback was determined to be supportive.   
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As providers who can deliver cost-effective and quality care, APRNs are uniquely 
suited for this type of enterprise.  Stringent collaborative practice laws, prescriptive 
authority and resistance to APRNs in Missouri may be a hindrance to advanced practice 
nurses who may otherwise be interested in this level of autonomy, but practicing at a 
certain level of independence is still very possible by observing the laws set forth for 
collaborative practice. 
LITERATURE REVIEW 
Epidemiologic Relevance of ADHD 
 ADHD affects 4.5 million 4 to 17 year-olds, with males outnumbering females 
3:1 across the diagnostic subtypes (CDC, 2010). Sixty to eighty percent of children who 
are diagnosed with ADHD as children meet the criteria as adolescents.  Up to 60% of 
those adolescents meet criteria as adults (McDonnell & Moffett, 2010; Elia, Acros-
Burgos, & Bolton, 2009; Bloom & Cohen, 2007; Kessler, Chiu, Demler, & Walters, 
2005).  In the general population, 9.2% of males and 2.9% of females are found to have 
behaviors consistent with ADHD.  The prevalence rate of ADHD is estimated to be 
approximately 8-10% of the school-age community (American Academy of Pediatrics, 
2009). 
Etiology of ADHD 
The etiology of ADHD is unknown, but there are a number of theoretical 
explanations associated with the disorder and there are clear genetic influences.  A twin 
study performed by Wilcutt, Olsen, and DeFries (2007), involved a comparison of the 
rate of concordance for ADHD in of monozygotic twins (twins who share all genes) 
versus dizygotic twins (twins who share half of their genes).  ADHD concordance rates 
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were significantly higher among monozygotic pairs (58-82%) versus same-sex dizygotic 
pairs (31-38%), providing evidence that ADHD has a genetic component.  Although there 
is no single marker identified yet, the genes that have been implicated in the development 
of ADHD include 5, 10, 12, 16, and 17 (Wilcutt et al., 2007).  More recently, both the 
DRD4 and DAT genes that regulate dopamine have been discovered to be deficient in 
children with ADHD (Kaplan & Adesman, 2011). 
The prefrontal cortex (PFC) of the brain is responsible for aggression, impulse 
control and inhibition.  Some propose that children with ADHD have an imbalance of 
noradrenaline, norepinephrine, and decreased dopaminergic regulation of neural circuits 
to the PFC (Da Silva, Szobot, Anselmi, Jackowski, & Chi, 2011). Characteristics of 
inattention and distraction appear to be caused by low levels of norepinephrine.  
Impulsivity and behavior problems appear to be caused by low levels of dopamine 
(Salmeron, 2009; Wilcutt et al., 2007).   
Researchers feel these changes in the circuitry are directly related to genetics.  
Serotonin, a neurotransmitter in the brain, has many functions in the body including 
regulating appetite, sleep, memory, learning, temperature regulation, mood, behavior, 
cardiovascular function, muscle contraction, and endocrine regulation (Porth, 2005).  
Tryptophan dyhydroxylase is responsible for serotonin production in maternal 
reproductive tissues (TPH1) and the brain (TPH2).  When these genes are mutated, 
serotonin production is impaired.   Impairments in TPH1 and TPH2 have been detected in 
mental health conditions such as depression, anxiety, autism, schizophrenia and ADHD 
(Halmy, Johansson, Winge, McKinney, & Knappskog, 2010).  A recent study from 
Norway indicated a new link might exist between decreased maternal levels of serotonin 
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and children with ADHD (Halmy et al., 2010).  Using a population of adults with a 
clinical diagnosis of ADHD who met the Diagnostic and Statistical Manual of Mental 
Disorders, Fourth Edition, Text Revision (DSM-IV-TR) criteria and randomly selected 
people from the general population as a control group, Halmy et al. identified that 
children of mothers with TPH1 variants were 1.5-2.5 times more likely to have ADHD 
than did children of fathers (P< .001) with TPH1 variants or the control group (P< 10
-6
). 
  Other theories concerning the risk factors inherent to the development of ADHD 
include environmental influences such as maternal health, maternal tobacco and/or 
alcohol use, fetal distress, low birth weight, and traumatic brain injury (CDC, 2010).    
ADHD Screening and Diagnosis 
There is no objective test to diagnose ADHD, and the diagnosis can be 
confounded by the presence of other psychiatric co-morbidities.  The American Academy 
of Pediatricians (AAP) and the American Academy of Child and Adolescent Psychiatry 
(AACAP) published guidelines to diagnose and manage ADHD based on criteria from 
the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision 
(DSM-IV-TR).  The guidelines are comprised of six recommendations with a high level 
of evidence-based support which states that a child age 4-18 who presents with 
inattention, hyperactivity, impulsivity, academic underachievement, or behavior 
problems should have an evaluation for ADHD (Table 1).  Screening tools can be used to 
assist in the diagnosis.  Data should be obtained from parents, caregivers, and teachers, 
and should include age of onset, duration of symptoms and the degree of functional 
impairment (AAP, 2011).  
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The Vanderbilt rating scale is one screening tool that is available in the public 
domain.  It screens for ADHD, and three other comorbidities: oppositional defiant 
disorder, conduct disorder, anxiety and depression.  The Vanderbilt scale includes parent 
and teacher versions and addresses inattentive, hyperactive and impulsive symptoms.  
Scoring is then completed by the primary care provider using the scoring guide.  Two 
other instruments that require per use fees are the Conner Assessment Scale, used for 
ADHD symptoms, and the Achenbach Child Behavior Checklist, which screens for 
multiple psychiatric conditions including depression, anxiety, conduct disorder, and 
oppositional defiant disorder.  
The National Initiative for Children’s Healthcare Quality (NICHQ) published the 
ADHD Toolkit based on to the AAP guidelines (NICHQ, 2011). The toolkit includes 
several tools for the diagnosis and treatment of children with ADHD including a 
Vanderbilt scale and a number of treatment resources.  These include guidelines for 
therapy selection, teacher report forms, and strategies to assist the clinician in monitoring 
the child.  English and Spanish versions of the toolkit are available.   
Table 1. 
Diagnostic Criteria for ADHD 
 
1.  Clinicians should initiate an evaluation in children ages 4-18 who present with 
inattention, hyperactivity, impulsivity, academic underachievement and behavior 
problems. 
2. The child must meet DSM-IV criteria before a diagnosis is made. 
3. Assessment requires data from parents, teachers and caregivers regarding the core 
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symptoms of ADHD in different settings.  The age of onset, degree of functional 
impairment and duration of symptoms must be recorded. 
3A. Assessment rating scales may be used when evaluating a child with ADHD. 
3B. Clinicians may use ADHD-specific rating scales when evaluating children with        
ADHD, but global questionnaires are not recommended. 
4.  Evidence must be obtained from teachers regarding core symptoms of ADHD, 
the degree of functional impairment, duration of symptoms, and coexisting 
conditions must be recorded. 
4A. Teachers may use the ADHD-specific rating scales. 
4B. Use of teacher global questionnaires and nonspecific behavior scales is not 
recommended in the diagnosis of children with ADHD, although they may be used 
for other purposes. 
5. The primary care provider should evaluate the child with ADHD for other 
coexisting disorders such as depression, anxiety, mood disorder, and conduct 
disorder. 
6. There is no scientific evidence that validates the use of any diagnostic test to 
establish the diagnosis of ADHD. 
Note.  Adapted from “ADHD Clinical Practice Guideline for the Diagnosis, Evaluation 
and Treatment of Attention Deficit/Hyperactivity Disorder in Children and Adolescents,” 
by the Subcommittee on Attention Deficit/Hyperactivity Disorder, Steering Committee 
on Quality Improvement and Management, 2011, Pediatrics, 128, p. 1007-1008. 
 
ADHD has three subtypes:  predominantly hyperactive-impulsive, predominantly 
inattentive, and combined hyperactive-inattentive.  In order to meet diagnostic criteria, 
the child must have six or more inattentive or impulsive symptoms, although 
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characteristics from the other categories may be present to a lesser degree (National 
Institute of Mental Health, 2009).   
Table 2 and Table 3 illustrate the categories and symptoms from the DSM-IV-TR 
for diagnosis of ADHD, as well as its subtypes.  Symptoms of hyperactivity and 
impulsivity include fidgeting, squirming, talking incessantly, touching everything in 
sight, and difficulty completing quiet tasks or activities.  The child with hyperactivity is 
in constant motion.  He or she is very impatient and has difficulty waiting their turn.  
They often blurt out answers or inappropriate comments.  They show no emotional 
restraint and act without regard for consequences.  They often interrupt conversations and 
others’ activities (NIMH, 2009).   
Table 2. 
  Characteristics by Subtype of ADHD 
IA.  Inattention IB.  Hyperactivity/Impulsivity 
 Careless mistakes in 
schoolwork or other 
activities 
 Fails to give close 
attention to details  
 Cannot sustain 
attention in tasks 
 Does not seem to 
listen when spoken to 
 Does not follow 
through on 
instructions 
 Fails to finish work 
or chores 
 Fidgets with hands/feet 
 Squirms in seat 
 Cannot stay seated 
 Has difficulty playing 
quietly or engaging in 
quiet activity 
 “On the go” 
 Seems “driven by 
motor” 
 Blurts out answers 
before questions are 
completed 
 Difficulty awaiting 
turn 
 Interrupts others 
Note. Adapted from “Diagnostic and Statistical Manual of Mental Disorders:  Attention 
Deficit and Disruptive Behavior Disorders,” by American Psychiatric Association, 2000, 
Fourth Edition, Text Revision. 
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Table 3. 
ADHD Subtypes 
IA.  Combined Type ADHD IB.  Predominantly Inattentive 
Type ADHD 
IC.  Predominantly 
Hyperactive/Impulsive 
ADHD 
If both criteria for IA. and 
IB. are met for past 6 months 
If criterion IA. is met, but IB. 
is not met for past 6 months 
If criterion IB. is met, 
but criterion IA. is not 
met for past 6 months 
Note. Adapted from “Diagnostic and Statistical Manual of Mental Disorders:  Attention 
Deficit and Disruptive Behavior Disorders,” by American Psychiatric Association, 2000, 
Fourth Edition, Text Revision. 
 
The child with inattention is easily distracted and misses details.  They are 
forgetful, and have difficulty with organization, completing a task, or learning something 
new.  They frequently switch from one activity to another.  They have difficulty focusing 
on one thing and become bored with a task after a few minutes unless it is enjoyable to 
them.  The inattentive child moves slowly, has trouble completing or turning in 
homework assignments, and loses things needed to complete them.  They daydream and 
do not seem to listen when spoken to.  They can become easily confused as they have 
difficulty processing information as quickly or as accurately as others. The child with 
combined-type has six or more symptoms in both categories, and may have symptoms 
that fit with one category at one time or others at another.  
Clinical practice guidelines state that the evaluation of a child or adolescent with 
ADHD should include assessment for other psychiatric conditions that may coexist with 
ADHD in the form of emotional (e.g. depression, anxiety), behavioral (e.g. oppositional, 
conduct), developmental (e.g. learning, language or other neurodevelopmental disorders), 
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disabilities and/or physical conditions (e.g. tics, sleep apnea) (AAP, 2011).  Clinicians 
should titrate medications to provide maximum benefit with minimum side effects.  This 
includes careful monitoring and consistent follow-up.  Longitudinal studies show that 
treatment is frequently not sustained despite the fact that children with ADHD are at risk 
for significant problems if left untreated.  Consistent behavioral treatment and careful 
monitoring are necessary for treatment adherence (AAP, 2011). 
According to a 2008 study performed by Epstein, Langberg, Lichtenstein, 
Mainwaring, and Luzader (2008), 52% of community physicians report they are aware of 
the clinical practice guidelines put forth by the AAP and AACAP;  however, only 35% 
report using all components.  A 2009 study done in Utah showed that advanced practice 
nurses follow the AAP diagnostic guidelines more closely than their physician 
counterparts (63.4% vs. 38.3%) (Vlam, 2006).  Consistently following AAP guidelines 
for ADHD diagnosis decreases the risk of over-diagnosis, misdiagnosis and under-
diagnosis (AAP, 2011).  Using the AAP guidelines as standard of care for the diagnosis 
of ADHD aids in properly identifying and treating the condition as early as possible, 
which improves the long-term outcomes and ensures a child has a chance at reaching 
their full potential (AAP, 2011).  
Treatment 
The management of ADHD should involve behavioral/psychological therapy, 
medication, or educational interventions alone or in combination (AAP, 2011).  A 
decision regarding the choice of how to treat each child should be individualized and 
must be done in collaboration with parents.  Both the provider and the parents must 
weigh the risks and benefits of the treatment strategy.  Goals must be set for realistic, 
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achievable and measurable outcomes. Examples of outcomes could be improved 
relationships with peers (e.g., playing without fighting at recess), improved academic 
performance (e.g., hands in homework on time), or improved rule following (e.g., raises 
hand to answer questions).  Behavioral interventions include modifications in the 
environment that are designed to change behavior.  Although considered an important 
strategy in ADHD treatment, they may fail to decrease the core ADHD symptoms of 
inattention, hyperactivity, and impulsivity. However, these interventions can improve 
other behavior problems often seen in the child with ADHD, such as depression, anxiety, 
aggression and self-worth.  Behavioral therapy is included in the treatment 
recommendations of the AAP and AACAP (Wolraich, Brown, Brown, DuPaul, & Earls, 
2011), and is considered first-line treatment for pre-school children ages 3-5 (Kaplan & 
Adesman, 2011). 
Behavioral modifications must include parent training and require consistency 
and patience and include activities such as time-out, response cost (taking away 
something when a negative behavior is identified), over-learning (practice procedures 
from beginning to end repeatedly), restitution (restoring what was lost during the 
misbehavior), positive reinforcement, simple charts to track desired behaviors, skill 
building, relaxation techniques, memory exercises and self-monitoring (Reiff, 2011). 
Psychostimulant medications are considered effective for children, adolescents 
and adults.  They are the most commonly used drugs and the most studied. At this time, 
only short-acting amphetamines are FDA-approved for use in children ages 3-5.  Side 
effects of psychostimulants include insomnia, anorexia, and weight loss, headache, 
tachycardia, increased blood pressure, and irritability. They can also worsen tics, so they 
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are only used when symptoms are profoundly impairing a child’s home or school life or 
when behavioral therapy has been ineffective (Kaplan & Adesman., 2011). 
In 2000, the Texas Children’s Medication Algorithm Project published an 
evidence-based algorithm for the pharmacotherapy of childhood ADHD (Pliszka, 2000).  
Pliszka et al. revised the algorithm in 2006, as the Texas Consensus Conference Panel on 
Pharmacotherapy of Childhood Attention Deficit-Hyperactivity Disorder.  The 
recommended order of treatment is psychostimulants, alternative psychostimulant 
(Cylert; with liver function tests every two weeks), antidepressant/nonstimulant 
(Strattera), alternative antidepressant (selective norepinephrine reuptake inhibitors, 
tricyclic acid antidepressants, monoamine oxidase inhibitors), and noradrenergic 
modulators such as clonidine for insomnia, or guanfacine for children who are 
predominantly hyperactive or impulsive, or who do not tolerate psychostimulants or 
Strattera (Strange, 2008).  There is a slight increase risk of suicide as well as liver disease 
with the use of Strattera.  Table 4 lists the medications prescribed in the treatment of 
ADHD. 
Table 4. 
Medications for ADHD 
Class Brand Name Daily Dose 
Mg/kg/day  
Daily Dosing 
Schedule 
Duration of 
Action 
Stimulants     
Dextroamphetamine Dexedrine 0.3-1.0 Twice daily, 
three times 
daily 
3-5 hours 
Mixed salts of L-
and D-amphetamine 
Adderall 0.5-1.5 Once daily, 
twice daily 
4-6 hours 
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Methylphenidate Ritalin 1.0-2.0 Twice daily, 
three times 
daily 
3-4 hours 
 Methylin 1.0-2.0 Twice daily, 
three times 
daily 
3-4 hours 
 Focalin 0.5-1.0 Twice daily, 
three times 
daily 
3-4 hours 
Extended-Release 
Formulations 
    
Dextroamphetamine Dexedrine 
Spansules 
0.3-1.0 Once to twice 
daily 
8-12 hours 
Methylphenidate Concerta 1.0-2.0 Once to twice 
daily 
10-12 hours 
 Ritalin LA 1.0-2.0 Once to twice 
daily 
8-9 hours 
 Metadate CD 1.0-2.0 Once to twice 
daily 
8-9 hours 
 Focalin XR 1.0-2.0 Once to twice 
daily 
10-12 hours 
 Daytrana 1.0-2.0 Once daily One patch 
once daily x 
9 hours, then 
off for 15 
hours 
 Methylin ER 1.0-2.0 Once to twice 
daily 
4-8 hours 
Mixed salts of L-
and D-amphetamine 
Adderall XR 0.5-1.5 Once to three 
times daily 
10-12 hours 
Lisdexamfetamine 
dimesylate 
Vyvanse 30-70mg/day Once daily  
Pemoline Cylert 56-75mg/day Once daily  
Non-stimulant 
Medications 
    
Noradrenergic-
Specific Reuptake 
Inhibitors 
    
Atomoxetine Strattera 0.5-1.4 Once to twice 
daily 
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Tricyclic 
Antidepressants 
    
Imipramine Tofranil 2.0-5.0 Once to twice 
daily 
 
Amitriptyline Elavil 2.0-5.0 Once to twice 
daily 
 
Clomipramine Anafranil 2.0-5.0 Once to twice 
daily 
 
Secondary Amines     
Desipramine Norpramin 1.0-2.0 Once to twice 
daily 
 
Nortriptyline Pamelor 1.0-3.0 Once to twice 
daily 
 
Other 
antidepressants 
    
Buproprion Wellbutrin 3.0-6.0 Once to twice 
daily 
 
 Wellbutrin 
SR 
3.0-6.0 Once to twice 
daily 
 
 Wellbutrin 
XL 
3.0-6.0 Once daily  
Noradrenergic 
Modulators 
    
Clonidine Catapres 0.003-0.010 Twice to 
three times 
daily 
 
Guanfacine Tenex 0.015-0.05 Once to twice 
daily 
 
Wakefulness-
Promoting Agents 
    
Modafinil  100-400mg Once daily  
Note.  Adapted from “Coming into Focus: Pharmacologic treatment for ADHD,” by M. 
McDonnell and C. Moffett, 2010, Advance for NPs and PAs 1(14), p. 16-22.  
 
A careful history and physical is recommended before prescribing stimulants. 
Vital signs, weight, appetite, abnormal movements (tics), sleep disturbance and growth 
should be monitored whenever psychostimulants are used (McDonnell & Moffett, 2010).  
In 2008, the American Heart Association released a statement that it was reasonable, 
though not mandatory, to consider ordering electrocardiogram (ECG)  in children with 
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ADHD before beginning a psychostimulant, because of the increased cardiac risk due to 
increased blood pressure and heart rate. They recommend ECG monitoring in children 
with cardiac history or in the case of family history of heart disease due to sudden cardiac 
death (Jensen, 2009).  The American Academy of Pediatrics countered this statement 
stating that sudden cardiac death is rare, happening in 1-2 out of one million children 
taking ADHD medications (AAP, 2008).   
Psychostimulants have also been implicated in growth impairment.  Altered 
growth is believed to be associated with anorexia secondary to stimulant use.  The AAP 
recommends clinicians use the best judgment for their patients (Harvard Medical School, 
2008). 
Unfortunately, the psychostimulant drug class has high abuse potential, which is a 
legitimate concern.  There are many reports of children selling their medication, and even 
other people or family members stealing, selling or taking the medication.  Some research 
indicates that stimulant medication seems to be protective against future substance abuse 
disorder in children and adolescents with a significant risk reduction (Wilens, Faraone, 
Biederman, & Gunawdene, 2003) in individuals with ADHD.  In this study, researchers 
examined 56 male adolescents with ADHD, 19 non-medicated male adolescents with 
ADHD, and 137 non-ADHD male adolescent control subjects for four years.  
Pharmacotherapy was associated with an 85% reduction (P<0.01) in risk of substance 
abuse disorder for any substance at follow-up; however, the results of the larger MTA 
study indicated that the actual risk for substance use neither increased or decreased in 
children and adolescents who were prescribed stimulants (Jensen, 2009; Molina et al., 
2009). 
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New medication preparations tend to discourage abuse potential, particularly the 
delivery system of the extended release formulations as well as the patch.  When the drug 
is released slowly and at low doses throughout the day, the rise of dopamine is slower 
and side effects such as euphoria are lessened.   Even extended release formulations have 
abuse potential because when taken inappropriately because dopamine levels can rise 
faster.  To lessen abuse potential, stimulants are controlled substances, and require an 
original prescription limiting the number of pills dispensed at one time.   
Literature suggests that medication in combination with cognitive behavioral 
therapy produces the best treatment outcomes (AAP, 2011; Wolraich et al., 2011; Jensen 
et al., 2009; Scottish Intercollegiate Guidelines, 2011; Pliszka, S., 2007).  To assess the 
effectiveness of each treatment, the MTA Study was performed. 
 The Multimodal Treatment Study of Children with ADHD (MTA) is the largest 
and most comprehensive clinical trial conducted in ADHD.  Five hundred seventy-nine, 
7-10 year old children with ADHD were randomly assigned to routine community care, 
medication, behavioral interventions, or combination therapy.  These children were then 
assessed at four different times in multiple outcomes.  Results indicated that combination 
therapy and medication were substantially superior to behavioral interventions and 
community care for ADHD symptoms. Improvement in social skills, academics, 
parent/child relations, oppositional behaviors, anxiety, and depression had slight 
advantages in combination therapy over medication, behavioral interventions and 
community care (Jensen et al., 2001).   
 At both the 14- and 24-month marks, researchers confirmed previous research, 
that although all children who received any type of treatment improved, the best results 
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occurred in children who received medication alone or in combination with behavioral 
therapy.  Surprisingly, that advantage began to diminish at 24 months and disappeared by 
36 months, even in children who consistently took their medication.  Researchers 
speculate that this occurred because children who participated in the study transitioned 
back to community care where they were not monitored as closely (Molina et al., 2009). 
IMPLICATIONS TO SOCIETY, ECONOMY AND HEALTH CARE: 
THE STAKEHOLDERS 
 ADHD is associated with impairments in many areas of children’s lives, including 
academic performance, social functioning, and overall quality of life.   Children with 
ADHD are more likely to have other co-morbidities such as learning disabilities, obesity, 
anxiety, depression, and tic disorder (Taurines et al., 2010).   Approximately 15% of 
children with ADHD (about 1% of the population) have co-morbidities of behavioral 
problems such as oppositional defiant disorder, conduct disorder, bipolar disorder, 
obsessive-compulsive disorder, and anti-social personality disorders (Bernfort, Norfelt, & 
Persson, 2007).   
Impairments caused by ADHD have major impacts on society, the economy, and 
healthcare.  Children with ADHD typically present with behavioral disturbances, 
restlessness, and poor social skills.  They exhibit difficulties in social relations and school 
environments.  Usually related to emotional factors and communication abilities, research 
indicates these children have low self-esteem and are frequently rejected by peers 
(Bernfort et al., 2007).  The question of stigma related to the diagnosis is raised, and other 
children may not tolerate the ADHD student’s behavioral issues as they are often 
disruptive.  Children with ADHD have difficulty adapting to school rules and routines.  
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These symptoms negatively affect academic performance and social development.  The 
adolescent with ADHD is more likely to become involved with deviant peer groups. They 
typically exhibit unsafe driving skills, have a higher rate of substance abuse, and have 
early initiation of smoking, marijuana, and inhalant use (Salmeron, 2009; Vierhile, Robb, 
& Ryan-Krause, 2009; Bernfort et al., 2007).   
 Adolescents with ADHD ages 12-18 are more likely than children without ADHD 
to be injured in a motor vehicle accident (Xiang, Stallones, Guanmin, Hostetler, & 
Kelleher, 2005).  Drivers tend to have slower reaction times, impulsiveness, poor vehicle 
handling, inconsistent rule following, and decreased attention.  In fact, drivers with 
ADHD are 1.88 times more likely to crash than those without ADHD (Jerome, Segal, & 
Habinski, 2006).  Children and adolescents with ADHD are also more accident-prone, 
having more broken bones, lacerations, head injuries, bruises, lost teeth and accidental 
poisonings than children without ADHD (Matza, Paramore, & Prasad, 2005).   
 School-aged children and adolescents with ADHD have poorer grades, more 
failed courses, and lower educational attainment than their non-affected peers (Bernfort et 
al., 2007).  Mannuzza, Klein, Bessler, Malloy, and Hynes (1997) found that young adults 
with a diagnosis of ADHD had on average two years less education than control groups.  
In a sample of 85 people with ADHD and 73 controls with a mean age of 24, 25% did not 
finish high school (compared to 1% of the controls), and 15% earned a Bachelor’s degree 
(compared to 50% controls).   
 Approximately 60% of children with a diagnosis of ADHD grow into adults with 
ADHD.  It is important to realize that adults with ADHD are also stakeholders (Vierhile 
et al., 2009).  These people exhibit lower rates of occupational attainment, difficulty 
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holding a job, frequent job changes, relationship discord, multiple marriages, and 
problems with the law such as being more likely to be arrested, convicted or incarcerated 
(Vierhile et al., 2009).   
 The societal cost of ADHD in childhood and adolescence was $42.5 billion in the 
United States, a total of $14, 576 per individual in 2005 (Vierhile et al., 2009).   Studies 
from 2005 consistently show that both children and adults with ADHD have an increased 
annual medical cost per individual than those without the diagnosis at $1,500 per child 
and $3,000 per adult.  In addition, family members of children with ADHD had 1.6 times 
as many medical claims as an individual without a family member with the diagnosis 
(Matza et al., 2005). 
 An ADHD diagnosis can also place a burden on family finances due to 
medication costs, treatment, and decreased work productivity as parents may miss work 
in order to meet with teachers, health care providers, or mental health professionals.  An 
estimated $86-138 billion in lost work productivity and education costs is associated with 
ADHD (Hodgkins, Kahle, & Sikirica, 2012).  Parents of children with ADHD report 
higher rates of self-blame, social isolation, depression, and marital discord (McDonnell & 
Moffett, 2010). 
Finally, ADHD places a burden on providers.  With an increased shortage of 
mental health specialists, it has required primary care providers to diagnose and treat 
ADHD.  Community-based clinicians are now the primary providers of services for 
children with ADHD and are often the first people patients see when a problem is 
noticed, usually as a referral from school (Bukstein, 2010).  Moreover, clinicians are 
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frequently asked about signs and symptoms of ADHD, so it is of utmost importance to 
understand not only the nature of the condition, but also the implications of the diagnosis. 
PROJECT DESCRIPTION 
In an effort to provide appropriate care to children and adolescents who may 
exhibit symptoms of ADHD, a center designed exclusively for the diagnosis and 
treatment of ADHD would fill a void in an area where access to mental health services 
is disparate.  Implementing a nurse-managed clinic for this purpose would add a 
resource for mental health care access, decrease rates of over-diagnosis, misdiagnosis 
and under-diagnosis of ADHD, and increase adherence to treatment.  Moreover, a 
nurse-managed clinic would establish advanced practice nurses as quality providers of 
care in the community.  The proposed resource center, called The ADHD Resource 
Center of Jefferson County, would be located in Jefferson County, a suburb of St. 
Louis, Missouri.  Evidence demonstrates that the best outcomes are obtained using 
psychostimulants, behavioral modification and counseling (Scottish Intercollegiate 
Guidelines, 2011; Wolraich et al., 2011; Jensen, 2009; Molina et al., 2009; Pliszka, 
2007).  The center would diagnose and manage children and adolescents ages 4-18 
with ADHD, offer behavioral therapy, individual and family counseling, and test for 
learning disabilities as approximately 40% of children with ADHD have a co-existing 
learning problem (Harvard Medical School, 2008; Wilcutt et al., 2007), using a 
multidisciplinary approach.  The center would operate by accepting referrals from 
primary care practices throughout Jefferson County and would accept payment from 
insurance companies.  In addition to cash payment system, the center would offer a 
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sliding scale fee-for-service for the underinsured.  To establish a referral base to 
support such a center, a need assessment survey needed to be performed. 
RATIONALE AND SUPPORT FOR THE PROJECT 
 A 2009 survey done by Thomas et al. illustrated that nearly all counties in the 
United States had some mental health prescriber shortage and three-fourths of all counties 
actually demonstrate severe shortage, limiting the number of resources available to 
patients.  Waiting lists to see a mental health care specialist can be up to a year long, and 
many providers limit the number of Medicare, Medicaid and self-pay patients they 
accept.  Many patients have an established rapport with a primary care office and they 
often visit there first (Bukstein, 2010; Minkoff, 2009; Pliszka, 2007).   
Unfortunately, there is documented discomfort among primary care physicians in 
the diagnosis and treatment of conditions such as depression, anxiety, bipolar disorder 
and ADHD.  In 2008, Fremont et al. conducted a survey demonstrating that pediatricians 
and family practice physicians had some level of discomfort in diagnosing and treating 
children with psychiatric disorders.  Pediatricians reported being more comfortable 
diagnosing and treating ADHD, while family practice physicians felt more comfortable 
with depression and anxiety.   
The shortage of mental health professionals has been a problem for many 
years, so much so that government involvement has led to the creation of legislation 
to make mental health care disparity a focus and a cause for reform.  In 1996, 
legislators forbade insurance companies to set annual or lifetime limits on mental 
health care.  In 2002, President George W. Bush endorsed the principle of mental 
health parity, meaning mental illnesses should be treated the same as physical 
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illnesses.  He established the New Freedom Commission on Mental Health.  This 
commission was to conduct a comprehensive study to identify policies that could be 
implemented by federal, state and local governments to improve mental health care 
in the United States by focusing on recovery and delivering excellent care without 
disparity (Konrad , Ellis, Thomas, Holzer, & Morrisey, 2009).  The commission 
reported that mental disorders often go undiagnosed and recommended screening for 
consumers of all ages, including preschoolers because “each year, children are 
expelled from preschools and child care facilities for disruptive behavior and 
emotional disturbances” (Department of Health and Human Services, 2003).  
Ultimately, the commission recommended improving the public’s knowledge 
regarding mental health, greater involvement of patients and families in decision-
making, creating individualized care plans, early screening and treatment, and more 
use of evidence-based practice (DHHS, 2003).   
 In 2008, the U.S. House of Representatives passed a bill requiring group health 
plans to provide more generous coverage for treatment of mental health, making it 
more comparable to physical illness coverage, and applying this coverage to any 
mental illness described in the current DSM.  This also includes treatment for drug 
and alcohol abuse (Pear, 2008). 
 Support for mental health parity stems from several factors.  First, researchers 
have identified biological causes for mental illness, reinforcing that it is a medical 
condition.  Second, there are many companies that specialize in managing mental 
health benefits, thereby making mental health treatment more affordable.  Finally, 
some feel that the stigma of mental illness is fading as more people in authority, 
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government and military admit to their own experience with mental illness (Pear, 
2008). 
 Despite this apparent increase in awareness and support, it is estimated that 
54% of people with serious mental illness still do not receive timely care (Konrad et 
al., 2009).  In 2009, there were 353,398 clinically active providers in six mental 
health groups in the United States workforce:  advanced practice psychiatric nursing, 
licensed professional counselors, marriage and family counselors, psychologists, 
psychiatrists, and social workers.  The advanced practice psychiatric nurse and 
psychiatrists made up the smallest percentage of the workforce.  Rural, low-income 
counties had the fewest mental health care providers per capita, where highly 
populated, high-income counties housed the most (Ellis, Konrad, Thomas, & 
Morrissey, 2009).   
 The disparity of mental health care providers in the rural counties has led to 
primary care providers being asked by parents and teachers to evaluate children and 
adolescents for ADHD.  (Bukstein, 2010; Power, Mautone, Manz, Frye, & Blum, 
2009).  As professionals who have taken on more roles as primary care providers, 
APRNs play a crucial role in the diagnosis and management of ADHD and are well-
suited to do so.  A 2008 systematic review of the literature published between 1990 
and 2008 by Newhouse et al. clearly establishes that APRNs provide similar, if not 
better care than physicians, had higher patient satisfaction rates, and could easily 
augment the physician in efforts aimed at expanding access to care.  Nurses are 
patient advocates, a quality necessary to assist patients and families to achieve goals 
at home and school (Vierhile et al., 2009).  As previously established, APRNs are 
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more likely to use clinical practice guidelines which aids in prompt diagnosis and 
effective treatment of ADHD, thereby lessening the impact of the condition (Vlam, 
2006). 
CHALLENGES FOR THE APRN 
Missouri Practice Act Restrictions 
 Despite a seemingly complex web of rules and regulations regarding advanced 
nursing practice in the state of Missouri, it is quite possible for the APRN to practice 
with a certain level of autonomy.  In order to practice as an advance practice 
registered nurse, APRNs must be board-certified by the state, and have a 
collaborative practice agreement with a physician with a similar specialty. APRNs 
that practice outside of their specialty must function at the level of the registered 
nurse.   
 Once a collaborative practice agreement is agreed upon and signed, the 
physician must work directly with the APRN for one calendar month before going 
off-site.  The physician is limited to three full-time equivalent collaborative practice 
agreements at one time. He or she must be within 30 miles of the APRN by road in a 
non-health professional shortage area, or 50 miles of the APRN by road in a 
designated health professional shortage area in order for the collaborative practice 
agreement to remain valid.   The collaborating physician must review 10% of the 
APRNs patients’ charts every two weeks, 20% where controlled substances have 
been prescribed.  In addition, this review and process must be documented and kept 
on file.  APRNs may write prescriptions, but prescriptions must conform to laws and 
contain the name address and telephone number of the APRN and collaborating 
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physician.  In addition, when sampling medications, APRNs are limited to 72 hour 
dispensing boundaries.  Drugs must be labeled, packaged and stored according to 
regulations.  Logs must be kept for dispensing them.  Methods of treatment and 
authority to administer, dispense or prescribe drugs delegated to the APRN cannot 
be further delegated.  Other regulations include that the diagnosis and initiation of 
treatment for acutely or chronically ill or injured conditions other than acute self-
limited or well-defined parameters be seen by the physician no more than two weeks 
later (Missouri Department of Professional Registration, 2012).    
 Recently, new legislation has been passed regarding prescriptive authority for 
APRNs in Missouri.  Provided the collaborating physician agrees for the APRN to 
prescribe controlled drugs and it is delegated in the collaborative practice agreement, 
Schedules III-V may now be prescribed by the APRN, but Schedule III is limited 
to120 hour supply without refill.  To obtain this authority, the APRN must submit a 
document of recognition, application and appropriate fee to the state board of 
nursing, current proof of certification, provide evidence of having a three credit hour 
pharmacology class within the past 5 years which must include 300 hours of 
preceptored experience or a letter from the university attended describing how this 
was accomplished within the curriculum. If not applicable, 45 continuing education 
hours in pharmacology may be submitted.  The APRN must also provide evidence of 
a minimum of 800 clinical practice hours as an APRN with the last 2 years.  Official 
transcripts must be sent.  Once the APRN receives controlled substance prescriptive 
authority, he or she may apply for a Board of Narcotics and Dangerous Drugs 
(BNDD) registration number and a federal Drug Enforcement Agency (DEA) 
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number.  Any restrictions on the collaborating physician’s BNDD number will apply 
to the APRN as well (Missouri Department of Professional Registration, 2012).  
Every two years, the APRN must provide evidence of a minimum of 800 clinical 
practice hours and 60 contact hours in their field of specialty offered by a university 
or accredited college.  They must adhere to all the requirements of the BNDD and 
DEA.     
If an APRN practices in a nurse-managed clinic, the above rules still apply and 
the physician must be present at the site at least once every 2 weeks (Missouri 
Department of Professional Registration, 2012).  However, in some specialties, such as 
mental health, and in rural areas, it can be difficult to find a collaborating physician, 
not to mention pay substantial fees for collaboration if he or she is practicing without a 
physician on site.   
Another barrier is reimbursement for APRNs.  In Missouri, APRNs are 
considered capable of being licensed independent providers by the Board of Nursing, 
Joint Commission on Accreditation of Healthcare Organizations, and all of the APRN 
certification organizations, however, numerous insurance companies will not 
reimburse Missouri APRNs for their services.  Like physicians, APRNs must apply for 
credentialing with each commercial managed care organization, health maintenance 
organization, commercial indemnity insurer, Medicare, and Medicaid.  The application 
process and approval takes time.  However, APRNs are considered “midlevel 
providers” or “physician extenders” and are not reimbursed the same fee-per-service 
as a physician despite carrying out the same task.  A Medicare patient seen for an 
existing condition by an APRN will only receive 85% of what a physician receives.   
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Some physicians are concerned that they are liable for care that they did not 
provide.  Reeducating physicians, multidisciplinary team members, legislators, and the 
public as the role of the APRN continues to be an ongoing endeavor.  Due to the 
restrictions in Missouri, the role of the APRN can be confusing because there is a lack 
of understanding about what the role entails.  Local and national organizations such as 
Missouri Nurses Association, The American Academy of Nurse Practitioners and The 
American Nurses Association continually publish literature clarifying the role, yet 
there is still a lack of respect for APRNs in the medical community.  Since 1974, 
numerous studies demonstrate that APRNs have increased patient satisfaction, 
increased patient compliance and outcomes equivalent to or better than physicians, but 
the American Medical Association continues to publish unsubstantiated reports 
questioning the safety of APRN practice (Missouri Nurses Association, 2012).     
Seventeen out of fifty states today do not require a collaborative practice 
agreement, and twenty-three only require one for prescribing (MONA, 2012).  APRNs 
still contribute to good health outcomes for their health care consumers.  Yet the war 
between medicine and nursing continues to deny the APRN recognition as a primary 
care provider in Missouri.  
IMPORTANCE TO HEALTH CARE AND NURSING PRACTICE 
 Cost-effective, quality medical treatment and access to care are national concerns.  
The statutory regulations that govern APRN scope of practice is determined by each 
state, causing regulations to vary greatly among the United States, thereby creating 
barriers to care.  These barriers directly affect access to healthcare and the cost and time 
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associated with healthcare delivery.  Missouri ranks 50 out of 51 areas in access to care 
(MONA, 2012).   
 According to the Missouri Nurses Association (2012), the Patient Protection and 
Affordable Care Act (PPACA) will introduce 374,000 patients by 2013 and 600,000 
patients by 2019.   Currently, Missouri has 6,000 APRNs practicing in rural and urban 
settings, and many of them are the only providers of care in healthcare shortage areas.  
Moreover, an aging physician population and fewer medical students entering primary 
care, access to care will continue to be profoundly affected.  These shortages contribute 
to poor health care outcomes, as the United States ranks 37
th
 in overall healthcare 
outcomes (MONA, 2012) despite spending that is double that of other industrial nations.  
With well-established research studies to support the role, the APRN is in a position to 
provide the type of care consumers need and at an affordable price.   
PROJECT ACTIVITIES AND METHODS 
Project Plan 
          The primary objective of this project was to develop a survey to determine provider 
receptiveness to referring patients to an APRN-managed center for the diagnosis and 
management of Attention Deficit/Hyperactivity Disorder.  A secondary aim of this 
project was to develop a business plan for the center, provided feedback from the surveys 
was determined to be supportive.  This business plan would have included a description 
of a potential clinic location, a budget describing the financial needs inherent in starting a 
clinic, the location and amount of money needed to start the practice, prospective staffing 
needs, as well as a list of services to be provided, evidence of the need for those services, 
projections for the practice’s income compared with expenses, a description of the 
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principal business owner, an organization plan, a plan for managing daily operations,  
potential problems and critical risks, as well as a plan for addressing or minimizing the 
risk.  In addition, marketing strategies and a timeline for opening the center would have 
been designed. This would have been accomplished by working closely with a mentoring 
APRN who is already established as an independent provider and business owner in the 
community. If the study proved that the center was infeasible, a business plan would not 
have been developed.   
Project Design 
 Dillman’s Tailored Design Method (TDM) provided the framework for survey 
creation and implementation.  This method increases survey return rates by 70%.  
Dillman, 2000).   
During this project, four contacts were made with subjects.  First, a pre-notice 
letter (Appendix A) was mailed to each subject describing the purpose of the survey.  
Five days later, an anonymous survey (Appendix B) was mailed to the subjects with a 
self-addressed, stamped return envelope.  Subjects were asked to complete the survey and 
return it to the principal investigator by a given deadline. One week later, a post card 
(Appendix C) was sent to all participants reminding them to complete the survey.   Two 
weeks after the postcard was sent, a thank you note and replacement survey (Appendix 
D) was mailed to all subjects along with a self-addressed, stamped envelope.  
Project Questions 
The primary project questions derived from the project objectives were: 
1. Do providers use clinical practice guidelines to diagnose and manage ADHD in    
children and adolescents ages 4-18? 
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2. What is the perceived comfort level of providers concerning diagnosis and 
management of ADHD in children and adolescents? 
3. Will providers refer their ADHD patients to a specialty center for diagnosis and 
management? 
4. Will providers refer their ADHD patients to a specialty center managed by an 
APRN? 
Project Setting 
 The project was conducted via United States Postal Service mail 
correspondence with participating physicians, APRNs and physician assistants practicing 
in pediatrics, family practice and internal medicine in Jefferson County, Missouri, a 
suburban area in the Midwestern United States. 
Project Participants 
 Eighty-four study participants were identified using a public directory of health 
care providers in Jefferson County, Missouri.  Of the 84 providers in the area, 75 
providers had a current address listed.  Eight subjects were listed by the post office as 
unable to forward, and one subject was deceased.  The subjects were not compensated for 
their participation in the project.  The following inclusion criteria were developed for 
participation: 
1. The subject must be a health care provider with the credentials of Medical 
Doctor (MD), Doctor of Osteopathy (DO), Nurse Practitioner (NP), or Physician 
Assistant (PA). 
2. The subject must currently work in internal medicine, family practice, or 
pediatrics in Jefferson County, Missouri. 
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3. The subject must treat children and adolescents ages 4-18. 
4. The subject must return the answered survey. 
Project Plan Awareness/Approval 
 This project was granted exempt status from University of Missouri, St. Louis 
Institutional Review Board.  University of Missouri, St. Louis Graduate School Approval 
was obtained August 7, 2012. 
Human Subject Protection 
 There were no human subject violations during the implementation of this 
project.  The surveys contained no identifying markers or information.  All surveys and 
responses were voluntary and anonymous.  
PROJECT METHODS 
Data Collection Timeline 
 Based on the TDM, it was decided that at least a 30% response rate was needed 
to determine feasibility of the proposed center.  Data collection commenced on August 8, 
2012 with the mailing of the pre-notice letter, the day after IRB Exempt Status and 
Graduate School approval was obtained.  The first survey was then mailed on August 13, 
2012.  Reminder postcards were sent a week later on August 20, 2012.  A thank you note 
and replacement survey was sent on September 4, 2012.  The last completed survey was 
received on September 16, 2012, marking the close of the project implementation 
process. 
DATA SUMMARY 
The primary purpose of this project was to determine if providers would refer 
their ADHD patients to a specialty clinic managed by an advanced practice nurse.  A 
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secondary aim of this project was to develop a business plan for the center, provided 
feedback was determined to be supportive.  To evaluate this, a total of 84 surveys were 
distributed to the providers identified in Jefferson County, Missouri.  Eight were unable 
to contact due to the inability to locate a current address, and one provider was deceased.  
A total of 34 surveys were returned, two were returned incomplete, resulting in a 
response rate of 42.7%.  This resulted in a final sample of 32 participants.  Table 5 
illustrates respondent’s credentials, and whether they treat children and adolescents or 
ADHD, information describing their practice, and insurance demographics. The two 
incomplete surveys were discarded from consideration.   
Table 5.   
Provider Demographics (n=32) 
 
Variable      Number Percent of Sample 
Profession description 
 MD      18  56.2%  
 DO      6  18.8% 
 NP      8  25.0% 
 
Multi-provider practice 
 Yes      27  84.4% 
 No      5  15.6% 
 
Ability to refer independently 
 Yes      30  93.8% 
 No      2  6.3% 
 
Willingness to refer independently 
 Yes      23  71.9% 
 No      6  18.8% 
 No answer     3  9.4% 
 
Treatment of children and adolescents 
 Yes      29  90.6% 
 No      3  9.4% 
 
Treatment of ADHD  
 Yes      28  87.5% 
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 No      3  9.4% 
 No answer     1  3.1% 
 
Description of Insurance Payer Mix 
 Medicare     0  0 
 Medicaid     0  0 
 Managed Care     1  3.1% 
 Third party/commercial   0  0 
 Self-pay     0  0  
 All of the above    14  43.8% 
 Some combination of the above  17  53.1% 
 
 The largest group of responders was the MD group (56.2%), followed by the NP 
group (25%), then the DO group (18.8%).  Nearly 91% of subjects reported treating 
children and adolescents, and 87.5% treated ADHD in their practice.  Most subjects 
reported practicing in a multi-provider group (84.4%), and would refer outside of their 
practice regardless of what their partners did (71.9%).  Just over half of the subjects 
answered they accepted a combination of insurance providers such as Medicare, 
Medicaid, managed care plans, third party/commercial, and self-pay patients (53.1%).  
Nearly 44% answered they accepted all the listed payers.   
             One subject was removed from analysis because he/she did not meet the 
inclusion criteria of treating ADHD and/or children and adolescents.  As a result, only 31 
subject responses were included in the analyses related to clinical practice guidelines use 
and willingness to refer to an ADHD center.  As both MDs and DOs have similar scopes 
and practices, and given the size of the survey, the MD and DO group were collapsed into 
one group for final analysis. 
Table 6. 
Provider Responses Regarding ADHD Clinical Practice Guidelines (CPG) (n = 31) 
 
Variable      Number Percent of Sample 
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Physician comfort level in diagnosing an managing ADHD (n=23) 
 Very comfortable    11   47.8%   
Comfortable     11   47.8%   
Uncomfortable    1   4.3% 
 
APRN comfort level in diagnosing and managing ADHD (n=8) 
 Very comfortable      1     1.2% 
 Comfortable      2     2.5% 
 Uncomfortable     4     50.0% 
 No answer      1     1.2% 
 
Physician Awareness of CPG (n=23) 
 Yes      19   82.6% 
 No       4   17.3% 
 
APRN Awareness of CPG (n=23) 
 Yes       7   87.5% 
 No       1   1.2% 
 
Physician Use of CPG (n=23) 
 Yes      15   65.2% 
 No       6   26.0% 
 Sometimes      1   4.3% 
 No Answer      1   4.3% 
 
APRN Use of CPG (n=8) 
 Yes      4    50% 
 No       3    37.5% 
 No Answer      1    1.2% 
 
Type of CPG Used (n=31) 
 AAP      14   45.2% 
 AACAP       1   3.2% 
 Both        5   16.1% 
 Neither       3   9.4% 
 Other        0   0 
 No answer       8   25.8% 
 
Portion of CPG Used (n=31) 
 Diagnosis       2   6.5%   
 Management       0   0     
 Follow-up       2   6.5% 
 All Parts     11   35.5% 
 Diagnosis, Management     3   9.7% 
 Diagnosis, Management, Follow-up    1                  3.2% 
 Management, Follow-up     1   3.2% 
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 No Answer     11   35.4% 
 
Note: *AAP= American Academy of Pediatrics, AACAP= American Academy of Child 
and Adolescent Psychiatry 
 
 Nearly the entire physician group responded they were either “Very Comfortable” 
(47.8%) or “Comfortable” (47.8%) with diagnosing and managing ADHD.  The majority 
of the NP group (50%) answered they were “Uncomfortable” with diagnosing and 
managing ADHD.  This is not reflected in the literature which states most physicians are 
uncomfortable diagnosing ADHD (Fremont et al., 2008). 
 The majority of both physicians and APRNs answered they were aware that CPGs 
for the diagnosis and management of ADHD existed (physician group 82.6% vs. NP 
group 87.5%) and that they used them to evaluate and treat their patients (physician 
group 65.2% vs. NP group 50%).  However, a substantial portion answered they did not 
use CPGs (physician group 26% vs. NP group 37.5%).  This is not mirrored in the 
literature which states the APRN tends to use CPGs more often than physicians 
(Abrahamson, Fox, & Doebbeling, 2012; Pogorzelska & Larson, 2008; Sinuff, Eva, 
Meade, Dodek, & Heyland, 2007; Vlam, 2006).  The most commonly cited CPG used is 
the American Academy of Pediatrics (45.2%).  A little more than a third (35%) said they 
used all parts of the CPGs to treat their patients.  It is important to note that 35.4% of 
subjects did not answer the question.  
 Table 7 illustrates the willingness of the provider to refer their ADHD patients not 
only to a specialty center, but a specialty center managed by an APRN.   
Table 7. 
Providers’ Willingness to Refer to Specialty Center  
 
Variable      Number Percent of Sample 
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Willingness to refer to an ADHD specialty center (n=23) 
 Yes      16  69.6% 
 No      7  30.4% 
 
Willingness to refer to an ADHD specialty center managed by APRN (n=23) 
 Yes      8  33.3% 
 No      15  62.5% 
  
APRN referral to specialty center (n=8) 
 Yes      8  100% 
 No      0  0 
 
APRN referral to specialty center managed by APRN (n=8) 
 Yes      7  87.5% 
 No      1   1.2% 
 
 Almost 70% of physician subjects expressed a willingness to refer to an ADHD 
specialty center in contrast to 100% of APRNs reporting they would refer to such a 
center.  However, when asked if they would refer to a specialty center for the diagnosis 
and management of ADHD by an APRN, less than half of those willing in the physician 
group would refer (33.3%). The majority of the NP group reported willingness to refer to 
an APRN-managed specialty center (87.5%), with one stating he or she could only refer 
to psychiatry per the collaborating physician.   
 These results were shared with the mentoring APRN, Angela Ames-Powers.  
Mrs. Powers stated she has to examine 18-20 patients per day in her clinic in order to 
maintain her income, pay overhead and pay her staff.  Sixteen (33%) of respondents 
stated they were willing to refer to an APRN-managed ADHD center.  In order to meet 
the minimum of 18 patient visits a day, 360 patients would need to be referred to the 
center per month.  These 16 providers would have to refer at least 22 patients per month 
in order for this center to remain open, an unlikely possibility. Dillman (2000), states that 
people feel uncomfortable when they do something inconsistent with their past behavior.  
ADHD Center  Stackley, 2012, UMSL 42 
Since people tend to behave consistently, it can be argued that the 41 subjects who did 
not respond to the survey would be unlikely to refer their ADHD patients to the clinic.   
Therefore the number of potential referrals was determined to be insufficient for 
establishing this type of center in Jefferson County, Missouri.  Because the feasibility of 
an advanced practice registered nurse-managed ADHD center was not established, a 
business plan was not developed. 
EVALUATION  
Provider Comfort Level 
In this study, 50% of the APRN group answered that they were “Uncomfortable” 
with diagnosing ADHD as compared with the physician group who were “Comfortable” 
to “Very Comfortable” (47.8% and 47.8%).  The comfort level of providers diagnosing 
and managing ADHD is relatively understudied.  Only one article was found regarding 
this subject and this project did not mirror those results which reported that APRNs were 
comfortable and more likely to use CPGs to diagnose and ADHD (Vlam, 2006).   
Provider Use of Clinical Practice Guidelines 
While both survey groups reported that they were aware of clinical practice 
guidelines, 45.2% reported they followed AAP recommendations and 35.4% did not use 
any CPGs in their management of children with ADHD. Further investigation is needed 
to determine how often these guidelines are used and why providers do not use the 
ADHD CPGs in practice.  Primary care pediatricians have complained of lack of clarity 
on how to interpret discrepancies in assessment, limited knowledge on community 
resources and how to identify which child needs a psychiatric evaluation (Power et al., 
ADHD Center  Stackley, 2012, UMSL 43 
2008).  More research is needed to determine the reasons APRNs are not as comfortable 
diagnosing and managing ADHD compared to the physician group. 
Providers’ Willingness to Refer to an APRN-Managed Center  
 Subjects were asked to explain why they would or would not refer to an APRN-
managed center.  While nearly 71% of physicians reported willingness to refer to an 
ADHD specialty center, less than half of that group would not refer to a specialty center 
managed by an APRN.  Some respondents made qualitative comments like “I can do it 
better,”  “the APRN has limited training and even less clinical experience,” and “most 
patients want to start out with a physician.”  Other respondents stated they would not use 
an APRN-managed center out of concern about the APRN role. An example of this type 
of comment is “APRNs cannot prescribe controlled substances, so prescribing may be an 
issue.”  One response was concerning the subject’s own practice. “Half of my patients are 
ADHD.  If I referred them, I wouldn’t see enough patients.”  While the latter is a 
legitimate concern, the majority of subjects did not answer why they would not refer to 
the APRN-managed center.   
 Research consistently shows APRNs are cost effective, provide quality care and 
have equal or improved health care outcomes as compared with physicians.  Many 
studies show that APRNs reduce hospital stays thus resulting in decreased cost of care, 
have low readmission rates, decreased emergency room use, decreased drug utilization, 
decreased laboratory cost and more use of preventative medicine (MONA, 2012).  
Further work needs to be done to study the issue of reluctance to refer to APRN-managed 
centers. 
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LIMITATIONS 
 There were several limitations to this study.  First, the sample size was 
relatively small, despite sending the survey to the 84 providers in Jefferson County and 
following the TDM framework.  Second, the survey was anonymous, thus limiting the 
ability to follow-up and clarify responses.  Asking providers’ specialty would have lent 
greater understanding to the results, such as which specialties were more comfortable 
diagnosing and managing ADHD, as well as which specialties would consider referring 
to an APRN-managed specialty center.  Third, the survey did not ask how many patients 
subjects would refer to the center, which could have given a better understanding of 
potential referral sources.  Finally, asking what diagnostic methods subjects use, such as a 
parent interview, observations, various rating scales, school reports could have 
established a better understanding of how ADHD is being diagnosed and perhaps why 
guidelines are not consistently used.  
BARRIERS AND CHALLENGES TO THE PROJECT 
 A challenge encountered with the project was ensuring that all of the providers 
in Jefferson County were invited to participate in the survey.  Using the most current 
issue of the local telephone directory was inaccurate as nearly 10% of the providers did 
not have a current address listed. The local hospital directory was consulted for the 
providers’ surveys that had been returned as “Unable to Forward,” and mailed again.       
APPLICATIONS FOR PRACTICE  
Implications for Further Research 
 This project yielded several implications for further research.  More work is 
needed to establish why clinical practice guidelines are not being used consistently to 
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diagnose and manage ADHD.  Important questions to study include:  If primary care 
providers are aware of the guidelines, why are they not being utilized?  Are they too 
cumbersome? For example, it is not certain if this discrepancy can be attributed to 
differences in the way APRNS and physicians are educated or if it is due to the roles that 
these clinicians assume after finishing their education.  However, it would be necessary 
to pair with a PhD-prepared nurse to develop means to investigate this understudied area.  
 Further work is needed to explore and explain the finding that physicians in this 
sample expressed a willingness to refer to an ADHD specialty center for diagnosis and 
management of ADHD, but not to a center managed by an APRN. This finding has 
profound implications not only for research, but for policy change.  Since 1974, research 
has established that the APRN provides safe, high quality, cost-effective care, equal to or 
better than physicians, but attitudes and beliefs regarding that care that APRNs give 
remains shrouded in mistrust.  Further research in this area is needed to continue to 
support positive change for the APRN role. 
DNP Education Influence on Personal APRN Practice 
DNP preparation can have a profound impact on professional nursing careers by 
enabling APRNs to translate research and apply evidence-based medicine in care 
provided to patients, thereby increasing the quality of that care.  This researcher is now 
familiar with clinical practice guidelines and uses them to consistently diagnose and 
manage ADHD.  DNP preparation was important during this project, because without it, 
an APRN could not have delved into the problem concerning the diagnosis and 
management of ADHD among primary care providers.  Without DNP preparation, a new 
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APRN would have difficulty seeing beyond individual patient care and affect changes in 
healthcare for aggregate groups.    
The DNP program also helps APRNs develop leadership skills and instills the 
confidence to foster change.  It opens minds and forces APRNs to think in broader 
directions.  While there is still a great deal of change to be wrought regarding the beliefs 
and attitudes of physician providers and the role of the APRN, only a leader can elicit 
input from all of the stakeholders and implement this change in order to move forward.  
This type of leader will be necessary to advocate for the APRN, educate physician 
providers regarding the role of the APRN, and assist in the continual evolution of the 
APRN role.   
Through this project, the DNP program has assisted in a personal quest to validate 
that there is inconsistency in the diagnosis and management of ADHD.  Most 
importantly, this researcher has come to understand her own child, and has made an effort 
to help other parents and children who have had similar experiences despite the 
infeasibility of this specialty center. 
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APPENDICES 
Appendix A.  First Contact: Pre-Notice Letter 
August 8, 2012 
 
Dear Sir or Madam: 
In a few days, you will receive a request to complete a brief questionnaire for a 
DNP scholarship project being conducted to discover provider’s beliefs about the 
diagnosis and management of Attention Deficit Hyperactivity Disorder in children and 
adolescents ages 4-18. 
 Your participation will involve receiving and/or completing: 
 an anonymous survey that will be mailed to you with a self-addressed, 
stamped return envelope 
 a reminder post card that will be mailed two weeks later 
 a replacement survey with another reminder letter that will be mailed two 
weeks later for those who may not have filled it out 
 
Approximately 90 subjects may be involved in this research.  
 
The amount of time involved in your participation will be approximately 5 minutes, 
and you will receive nothing for your time.   There are no anticipated risks associated 
with this research.  There are no direct benefits for you participating in this study. 
However, your participation will contribute to the knowledge about providers’ beliefs 
regarding the diagnosis and management of Attention Deficit Hyperactivity Disorder in 
children and adolescents ages 4-18 Jefferson County Missouri, and may help society.  
Your participation is voluntary and you may choose not to participate in this research 
study or to withdraw your consent at any time. You may choose not to answer any 
questions that you do not want to answer. You will NOT be penalized in any way should 
you choose not to participate or to withdraw.  
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By agreeing to participate, you understand and agree that your data may be shared 
with other researchers and educators in the form of presentations and/or publications. In 
all cases, your identity will not be revealed. In rare instances, a researcher's study must 
undergo an audit or program evaluation by an oversight agency (such as the Office for 
Human Research Protection). That agency would be required to maintain the 
confidentiality of your data. In addition, all data will be stored on a password-protected 
computer and/or in a locked office. 
If you have any questions or concerns regarding this study, or if any problems arise, 
you may call the Principle Investigator, Kara J. Stackley (636)448-3844 or the Faculty 
Advisor, Dawn Garzon, (314) 516-7094.  You may also ask questions or state concerns 
regarding your rights as a research participant to the Office of Research Administration, 
at (314) 516-5897. 
Thank you for your time and consideration.  Without your input, research for this area 
of need could not be completed. 
Sincerely,  
 
Kara J. Stackley, FNP-BC 
 
University of Missouri, St. Louis 
 
 
 
ADHD Center  Stackley, 2012, UMSL 57 
Appendix B.  Second contact:  The Questionnaire Mail-out              
August 13, 2012 
 
Dear Sir or Madam,  
 
I am seeking your assistance for completion of a DNP scholarship project 
regarding providers’ beliefs about the diagnosis and management of Attention 
Deficit/Hyperactivity Disorder in children and adolescents ages 4-18.   
To participate in this study, simply answer the survey questions, place the 
completed survey in the enclosed self-addressed, stamped envelope and drop it in the 
mail. It should take approximately 5 minutes to complete.  Please be advised that the 
survey is completely anonymous and there is no way to know who has or has not 
completed it.  No identifying information will be collected. 
By returning the questionnaire, you are providing consent to participate in this 
study.  The research team values your opinion.  You can elect to not participate in this 
study, and you may choose to answer or not answer any question.  Please call me with 
any questions or concerns at (636)448-3844.  You can also call the Office of Research 
Administration at (314)516-5897 regarding your rights as a research participant. 
Your response would be appreciated by August 23, 2012. 
Sincerely, 
 
Kara J. Stackley, FNP-BC 
 
University of Missouri-St. Louis 
 
 
 
 
ADHD Center  Stackley, 2012, UMSL 58 
Need Assessment Survey 
 
1. Describe your profession: 
 
MD  DO  NP  PA 
 
2. Do you treat children and adolescents in your office? 
 
Yes    No 
 
3. Do you treat ADHD in your office? 
 
Yes    No 
 
4. What is your comfort level regarding the diagnosis and management of ADHD in   
children and adolescents? 
 
        Very comfortable  Comfortable  Uncomfortable 
 
5. Are you aware of clinical practice guidelines for the diagnosis and management of           
ADHD? 
 
Yes    No                    Unaware 
 
6. If you are aware of clinical practice guidelines for the diagnosis and management 
of ADHD, do you use them in your practice? 
 
Yes    No   
 
7. If you do use clinical practice guidelines for ADHD in your practice, which ones 
do you use? 
 
AAP       AACAP             Both     Neither 
        
Other____________ 
 
8. If you use clinical practice guidelines for ADHD in your practice, which part of 
the guidelines do you use? 
 
Diagnosis  Management (behavior mod, medication, combination therapy)  
 
  
Follow-up   All parts of the guidelines 
 
9. Would you consider referring your ADHD patients to a specialty center for 
diagnosis and management? 
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Yes   No If no, why not?    
____________________________________________________________
____________________________________________________________
____________________________________________________________
____________________________________________________________ 
 
10. Would you consider referring your ADHD patients to a specialty center solely for 
the purpose of diagnosis and management of ADHD performed by a family nurse 
practitioner who is practicing within the rules and regulations of the state of 
Missouri? 
 
Yes   No If no, why not?    
____________________________________________________________
____________________________________________________________
____________________________________________________________
____________________________________________________________ 
 
11. Are you in a multi-provider practice? 
 
Yes  No 
 
12. Do you have the ability to refer patients independently? 
 
Yes  No 
 
13. If yes, would you refer your patients to a specialty center solely for the purpose of 
diagnosis and management of ADHD regardless of wheat your collaborators do? 
  
Yes  No 
 
14. Please describe your insurance demographics: 
 
Medicare Medicaid Managed Care  Third party/commercial         
 
Self-pay 
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Appendix C.  Third Contact: The Reminder Post Card 
August 20, 2012 
 
 Last week, a survey was sent to you seeking your responses regarding providers’ 
beliefs about the diagnosis and management of Attention Deficit/Hyperactivity Disorder 
in children and adolescents ages 4-18. 
 If you have already completed your survey, please accept my sincere thanks.  If 
not, please do so today.  I am especially grateful for your help because it is through your 
input and thoughts that research in this area can expand.  Because all surveys are 
anonymous, I have no way of knowing who has or has not already responded. 
 If you did not receive a questionnaire, if it was misplaced, or you have questions 
or concerns, please call (636)448-3844.  You may also call the Office of Research 
Administration at (314)516-5867 regarding your rights as a research participant. 
 
 
Kara Stackley, FNP-BC 
 
University of Missouri-St. Louis 
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Appendix D.  Fourth Contact: The Reminder Post Card with Replacement Survey 
September 4, 2012 
Dear Sir or Madam: 
About two weeks ago, I sent a survey to you that asked for your input regarding 
providers’ beliefs about the diagnosis and management of Attention Deficit Hyperactivity 
Disorder in children and adolescents ages 4-18.   
I am looking for your input regarding the diagnosis and management of Attention 
Deficit Disorder in children and adolescents ages 4-18 and how it applies to your 
practice.  I want to stress the importance of how you practice provides information to 
further the research in this particular field.  If you have already returned it, thank you in 
advance and please disregard this letter.   
If you haven’t yet completed the survey, a replacement has been enclosed.   If you 
have not already responded, please complete the enclosed questionnaire, place it in the 
enclosed self-addressed, stamped envelope, and drop it in the mail. It should take about 5 
minutes to complete.  By returning the survey, you are providing consent to participate in 
this study.  You can elect to not participate in this study, and you may choose to answer 
or not answer each question. 
Please be advised that the survey is completely anonymous, and there is no way 
for me to know who has or has not completed it.  No identifying information will be 
collected, and this is the final time you will be contacted.  Please call me at (636)448-
3844 with any questions or concerns.  You may also call the Office of Research 
Administration at (314)516-5897 regarding your rights as a research participant. 
Your response would be appreciated by September 15, 2012, 
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Sincerely, 
 
Kara J. Stackley, FNP-BC 
 
University of Missouri-St. Louis 
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Need Assessment Survey 
 
1.  Describe your profession: 
 
MD  DO  NP  PA 
 
 
2.  Do you treat children and adolescents in your office? 
 
Yes    No 
 
3. Do you treat ADHD in your office? 
 
Yes    No 
 
4. What is your comfort level regarding the diagnosis and management of ADHD in   
children and adolescents? 
 
        Very comfortable  Comfortable  Uncomfortable 
 
5. Are you aware of clinical practice guidelines for the diagnosis and management of           
ADHD? 
 
Yes    No                    Unaware 
 
6. If you are aware of clinical practice guidelines for the diagnosis and management 
of ADHD, do you use them in your practice? 
 
Yes    No   
 
7. If you do use clinical practice guidelines for ADHD in your practice, which ones 
do you use? 
 
AAP       AACAP             Both     Neither     
Other____________ 
 
8. If you use clinical practice guidelines for ADHD in your practice, which part of 
the guidelines do you use? 
 
Diagnosis  Management (behavior mod, medication, combination therapy)  
 
  
Follow-up   All parts of the guidelines 
 
9. Would you consider referring your ADHD patients to a specialty center for 
diagnosis and management? 
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Yes   No  If no, why not?    
____________________________________________________________
____________________________________________________________
____________________________________________________________
____________________________________________________________ 
 
10. Would you consider referring your ADHD patients to a specialty center solely for 
the purpose of diagnosis and management of ADHD performed by a family nurse 
practitioner who is practicing within the rules and regulations of the state of 
Missouri? 
Yes   No  If no, why not?    
____________________________________________________________
____________________________________________________________
____________________________________________________________
____________________________________________________________ 
 
11. Are you in a multi-provider practice? 
 
Yes  No 
 
12. Do you have the ability to refer patients independently? 
 
Yes  No 
 
13. If yes, would you refer your patients to a specialty center solely for the purpose 
of diagnosis and management of ADHD regardless of wheat your collaborators 
do? 
  
Yes  No 
 
14. Please describe your insurance demographics: 
 
Medicare Medicaid        Managed Care         Third party/commercial        
Self-pay 
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